Zentiva has bolstered its consumer health offering in Italy with the acquisition of two OTC brands from Sanofi for an undisclosed sum.
Through the deal, Zentiva Italia will enter the cold and flu category with the Zerinol range and expand its
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?